NVAX logo

Novavax (NVAX) Shareholders equity

annual shareholders equity:

-$623.84M+$93.09M(+12.98%)
December 31, 2024

Summary

  • As of today (May 21, 2025), NVAX annual stockholders equity is -$623.84 million, with the most recent change of +$93.09 million (+12.98%) on December 31, 2024.
  • During the last 3 years, NVAX annual shareholders equity has fallen by -$272.17 million (-77.39%).
  • NVAX annual shareholders equity is now -199.46% below its all-time high of $627.21 million, reached on December 31, 2020.

Performance

NVAX Shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXbalance sheet metrics

quarterly shareholders equity:

-$75.64M+$548.20M(+87.87%)
March 31, 2025

Summary

  • As of today (May 21, 2025), NVAX quarterly stockholders equity is -$75.64 million, with the most recent change of +$548.20 million (+87.87%) on March 31, 2025.
  • Over the past year, NVAX quarterly shareholders equity has increased by +$791.44 million (+91.28%).
  • NVAX quarterly shareholders equity is now -107.28% below its all-time high of $1.04 billion, reached on March 31, 2021.

Performance

NVAX quarterly shareholders equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXbalance sheet metrics

Shareholders equity Formula

Shareholders Equity = Total Assets − Total Liabilities

NVAX Shareholders equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+13.0%+91.3%
3 y3 years-77.4%-215.8%
5 y5 years-235.4%-215.6%

NVAX Shareholders equity Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-77.4%+13.0%-215.8%+91.5%
5 y5-year-199.5%+13.0%-107.3%+91.5%
alltimeall time-199.5%+13.0%-107.3%+91.5%

NVAX Shareholders equity History

DateAnnualQuarterly
Mar 2025
-
-$75.64M(-87.9%)
Dec 2024
-$623.84M(-13.0%)
-$623.84M(+18.5%)
Sep 2024
-
-$526.44M(+21.9%)
Jun 2024
-
-$431.71M(-50.2%)
Mar 2024
-
-$867.08M(+20.9%)
Dec 2023
-$716.93M(+13.1%)
-$716.93M(+5.7%)
Sep 2023
-
-$678.35M(-10.1%)
Jun 2023
-
-$754.52M(-15.8%)
Mar 2023
-
-$895.58M(+41.2%)
Dec 2022
-$634.08M(+80.3%)
-$634.08M(+12.0%)
Sep 2022
-
-$565.99M(+35.7%)
Jun 2022
-
-$416.95M(-738.3%)
Mar 2022
-
$65.32M(-118.6%)
Dec 2021
-$351.67M(-156.1%)
-$351.67M(-176.2%)
Sep 2021
-
$461.34M(-38.1%)
Jun 2021
-
$745.56M(-28.3%)
Mar 2021
-
$1.04B(+65.7%)
Dec 2020
$627.21M(-437.2%)
$627.21M(+489.3%)
Sep 2020
-
$106.44M(-42.3%)
Jun 2020
-
$184.53M(-869.8%)
Mar 2020
-
-$23.97M(-87.1%)
Dec 2019
-$186.02M(+10.8%)
-$186.02M(-2.0%)
Sep 2019
-
-$189.84M(+2.3%)
Jun 2019
-
-$185.49M(+23.2%)
Mar 2019
-
-$150.58M(-10.3%)
Dec 2018
-$167.94M(+65.1%)
-$167.94M(+32.6%)
Sep 2018
-
-$126.68M(+44.4%)
Jun 2018
-
-$87.71M(-11.7%)
Mar 2018
-
-$99.37M(-2.3%)
Dec 2017
-$101.73M(+1734.3%)
-$101.73M(+37.2%)
Sep 2017
-
-$74.15M(+25.5%)
Jun 2017
-
-$59.06M(+103.0%)
Mar 2017
-
-$29.10M(+424.7%)
Dec 2016
-$5.55M(-101.9%)
-$5.55M(-111.1%)
Sep 2016
-
$49.78M(-54.8%)
Jun 2016
-
$110.12M(-40.6%)
Mar 2016
-
$185.43M(-36.6%)
Dec 2015
$292.67M(+27.5%)
$292.67M(-20.3%)
Sep 2015
-
$367.02M(-5.3%)
Jun 2015
-
$387.60M(-3.0%)
Mar 2015
-
$399.71M(+74.1%)
Dec 2014
$229.62M(+13.0%)
$229.62M(-12.2%)
Sep 2014
-
$261.65M(-7.1%)
Jun 2014
-
$281.73M(+47.5%)
Mar 2014
-
$191.06M(-6.0%)
Dec 2013
$203.23M(+153.3%)
$203.23M(-6.2%)
Sep 2013
-
$216.57M(+212.9%)
Jun 2013
-
$69.23M(-10.8%)
Mar 2013
-
$77.57M(-3.3%)
Dec 2012
$80.24M(+49.0%)
$80.24M(+30.7%)
Sep 2012
-
$61.38M(+0.5%)
Jun 2012
-
$61.08M(+12.4%)
Mar 2012
-
$54.32M(+0.9%)
Dec 2011
$53.85M(-8.8%)
$53.85M(-1.4%)
Sep 2011
-
$54.60M(-3.0%)
Jun 2011
-
$56.27M(+5.1%)
Mar 2011
-
$53.53M(-9.3%)
Dec 2010
$59.05M
$59.05M(-11.9%)
DateAnnualQuarterly
Sep 2010
-
$66.99M(+16.5%)
Jun 2010
-
$57.52M(-8.9%)
Mar 2010
-
$63.14M(-9.7%)
Dec 2009
$69.95M(+53.8%)
$69.95M(+4.4%)
Sep 2009
-
$67.02M(+12.2%)
Jun 2009
-
$59.72M(+58.0%)
Mar 2009
-
$37.79M(-16.9%)
Dec 2008
$45.49M(-27.9%)
$45.49M(-19.0%)
Sep 2008
-
$56.13M(+18.9%)
Jun 2008
-
$47.22M(-15.4%)
Mar 2008
-
$55.80M(-11.5%)
Dec 2007
$63.06M(-32.9%)
$63.06M(-12.3%)
Sep 2007
-
$71.88M(-10.4%)
Jun 2007
-
$80.26M(-7.9%)
Mar 2007
-
$87.11M(-7.3%)
Dec 2006
$94.00M(+89.3%)
$94.00M(-5.2%)
Sep 2006
-
$99.14M(-4.5%)
Jun 2006
-
$103.83M(-4.8%)
Mar 2006
-
$109.11M(+119.7%)
Dec 2005
$49.65M(+49.2%)
$49.65M(+149.5%)
Sep 2005
-
$19.90M(+6.5%)
Jun 2005
-
$18.69M(-23.4%)
Mar 2005
-
$24.39M(-26.7%)
Dec 2004
$33.28M(-7.4%)
$33.28M(-23.6%)
Sep 2004
-
$43.54M(+86.6%)
Jun 2004
-
$23.34M(-24.1%)
Mar 2004
-
$30.75M(-14.5%)
Dec 2003
$35.94M(+345.2%)
$35.94M(+180.1%)
Sep 2003
-
$12.83M(-20.4%)
Jun 2003
-
$16.12M(-18.1%)
Mar 2003
-
$19.70M(+144.0%)
Dec 2002
$8.07M(-70.6%)
$8.07M(-38.1%)
Sep 2002
-
$13.04M(-34.1%)
Jun 2002
-
$19.77M(-14.1%)
Mar 2002
-
$23.03M(-16.2%)
Dec 2001
$27.49M(-13.6%)
$27.49M(-8.3%)
Sep 2001
-
$30.00M(+2.5%)
Jun 2001
-
$29.28M(-3.3%)
Mar 2001
-
$30.27M(-4.9%)
Dec 2000
$31.82M(+1036.6%)
$31.82M(+155.4%)
Sep 2000
-
$12.46M(-16.5%)
Jun 2000
-
$14.92M(-14.6%)
Mar 2000
-
$17.47M(+524.0%)
Dec 1999
$2.80M(-6.7%)
$2.80M(-20.0%)
Sep 1999
-
$3.50M(-32.7%)
Jun 1999
-
$5.20M(+147.6%)
Mar 1999
-
$2.10M(-30.0%)
Dec 1998
$3.00M(-53.8%)
$3.00M(-69.4%)
Sep 1998
-
$9.80M(-9.3%)
Jun 1998
-
$10.80M(-8.5%)
Mar 1998
-
$11.80M(+81.5%)
Dec 1997
$6.50M(+27.5%)
$6.50M(-9.7%)
Sep 1997
-
$7.20M(-11.1%)
Jun 1997
-
$8.10M(-11.0%)
Mar 1997
-
$9.10M(+78.4%)
Dec 1996
$5.10M
$5.10M(+4.1%)
Sep 1996
-
$4.90M(-10.9%)
Jun 1996
-
$5.50M(-12.7%)
Mar 1996
-
$6.30M

FAQ

  • What is Novavax annual stockholders equity?
  • What is the all time high annual shareholders equity for Novavax?
  • What is Novavax annual shareholders equity year-on-year change?
  • What is Novavax quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Novavax?
  • What is Novavax quarterly shareholders equity year-on-year change?

What is Novavax annual stockholders equity?

The current annual shareholders equity of NVAX is -$623.84M

What is the all time high annual shareholders equity for Novavax?

Novavax all-time high annual stockholders equity is $627.21M

What is Novavax annual shareholders equity year-on-year change?

Over the past year, NVAX annual stockholders equity has changed by +$93.09M (+12.98%)

What is Novavax quarterly stockholders equity?

The current quarterly shareholders equity of NVAX is -$75.64M

What is the all time high quarterly shareholders equity for Novavax?

Novavax all-time high quarterly stockholders equity is $1.04B

What is Novavax quarterly shareholders equity year-on-year change?

Over the past year, NVAX quarterly stockholders equity has changed by +$791.44M (+91.28%)
On this page